LINKER-MM4

Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma

Arms / Cohorts

Experimental, Phase 1:Linvoseltamab: Treatment Naive Patients

Accepting patients

Experimental, Phase 2:Linvoseltamab: Transplant Ineligible Cohort

Not yet accepting

Experimental, Phase 2:Linvoseltamab: Transplant Eligible Cohort

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.